Related Experiment Video

Updated: Jul 10, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

[Rheumatoid arthritis and atherosclerosis]

Claiton Viegas Brenol1, Odirlei André Monticielo, Ricardo Machado Xavier

  • 1Serviço de Reumatologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul. claiton.brenol@gmail.com

Revista Da Associacao Medica Brasileira (1992)
|October 24, 2007
PubMed

Insights

Rheumatoid arthritis (RA) patients face higher cardiovascular disease risks due to accelerated atherosclerosis. Managing traditional and inflammatory factors can reduce RA-related cardiovascular events and mortality.

Area of Science:

  • Rheumatology
  • Immunology
  • Cardiology

Context:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease causing joint inflammation.
  • RA patients exhibit a significantly higher prevalence of cardiovascular disease (CVD) and mortality.
  • Accelerated atherosclerosis, driven by traditional CVD risk factors and systemic inflammation, underlies this increased risk.

Purpose:

  • To explore the link between rheumatoid arthritis and accelerated atherosclerosis.
  • To identify key risk factors contributing to cardiovascular events in RA patients.
  • To highlight the potential for risk factor management to mitigate RA-associated CVD.

Summary:

  • RA involves systemic inflammation, endothelial dysfunction, insulin resistance, dyslipidemia, and oxidative stress, all contributing to atherosclerosis.
  • Traditional cardiovascular risk factors (smoking, hypercholesterolemia, hypertension, diabetes) are prevalent in RA.
  • Inflammatory markers like high erythrocyte sedimentation rate and C-reactive protein correlate with cardiovascular events in RA.

Impact:

  • Identifying and controlling modifiable risk factors in RA can reduce atherosclerosis progression.
  • Effective management strategies may decrease cardiovascular morbidity and mortality in rheumatoid arthritis patients.
  • This research supports a proactive approach to cardiovascular health in autoimmune rheumatic diseases.

More Related Videos

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...